Building Your Care Team: Navigating Ultra-Rare Care
At a Glance
People with LMNA-related cardiocutaneous progeria syndrome (LCPS) benefit from coordinated care for heart rhythm and valve disease, lipodystrophy and metabolic problems, skin changes, and emotional health. A complete medical passport helps local clinicians work with rare-disease experts.
Managing an ultra-rare condition like LMNA-related cardiocutaneous progeria syndrome (LCPS) requires more than a standard medical team. Because this condition affects multiple systems—from the electrical timing of your heart to the way your body processes sugar—your care should ideally be guided by a multidisciplinary reference center [1].
However, if physical access to such a center is not possible, your local primary care doctor, cardiologist, and endocrinologist can often coordinate your care effectively by consulting remotely with LMNA experts.
Your Core Specialist Team
A successful care plan for LCPS relies on several specialists working together:
- Cardiology and Electrophysiology: This is the most critical part of your team. They manage the “electrical” risks (arrhythmias) and the “mechanical” issues (valve calcification) [2]. An electrophysiologist focuses specifically on your heart’s rhythm and the potential need for an ICD [3].
- Valve / Cardiothoracic Surgery Team: Given the high risk of severe calcific valve disease in LCPS, you may need a specialized surgical team to plan for eventual valve replacement or repair.
- Clinical Genetics: A genetic counselor or geneticist confirms your diagnosis and helps you understand your specific LMNA variant [4]. They also provide counseling for your family members, as early screening for relatives is considered when a pathogenic or likely pathogenic variant is confirmed [2].
- Endocrinology and Metabolism / Dietitian: These specialists manage the lipodystrophy (fat loss) and the resulting metabolic issues like insulin resistance, high triglycerides, and fatty liver disease [5]. A specialized dietitian is also a crucial partner in this process.
- Dermatology: A dermatologist monitors the “cutaneous” (skin) features of LCPS, such as thinning skin, hair loss, and mottled pigmentation [6].
- Mental Health Support: Managing an inherited condition carries a heavy psychological burden; a cardiac psychologist or counselor can be vital for coping.
Preparing Your “Medical Passport”
Because LCPS is so rare, you are often the most important carrier of your own medical data. Do not rely solely on hospitals to send records to each other; bring physical copies or digital files of the following baseline tests to your first visit:
- Genetic Testing Report: Ensure you have the full laboratory report showing the specific mutation (e.g., p.Asp300Gly or p.Glu2Lys) and whether it is classified as “pathogenic,” “likely pathogenic,” or a “variant of uncertain significance” (VUS) [7].
- Cardiac Imaging: Bring the actual images (on a CD or digital portal) for your Echocardiogram (to check valves) and Cardiac MRI with late gadolinium enhancement (LGE) [8][9]. LGE is used to look for scarring in the heart muscle [10].
- Rhythm Monitoring: Provide results from any 24-hour Holter or long-term ambulatory monitors you have worn.
- Metabolic Panels: Bring your most recent labs for HbA1c, fasting glucose, triglycerides, and liver enzymes [11][5].
- Renal and Bone Screen: If available, include results for urine protein (to check kidney health) and DXA scans (for bone density) [12][13].
Verifying Expertise
When meeting a new specialist, it is okay to ask questions to ensure they have the right experience for an ultra-rare laminopathy. A qualified clinician or team should:
- Be familiar with the LMNA arrhythmia risk calculator, which is used to guide discussions about ICD placement [14].
- Have experience managing lipodystrophy and understanding how it differs from standard Type 2 diabetes [11].
- Participate in or have access to international registries or research networks, which—while not the only proof of expertise—can indicate they are up-to-date on the latest LCPS evidence [15].
By assembling the right team and arriving prepared, you shift the focus from “finding a diagnosis” to “proactively managing your future.”
Common questions in this guide
Which specialists should be part of an LCPS care team?
Can local doctors manage LCPS if I cannot reach a rare-disease reference center?
What records should I bring to my first LCPS specialist visit?
How is the LMNA arrhythmia risk calculator used?
What can a genetic counselor tell my family about LCPS?
Why do people with LCPS need an endocrinologist and dietitian?
Why should I bring the original cardiac MRI and echocardiogram images?
Appointments are short. Make every minute count.
Specialist visits move fast. Let us help you prep so your time goes to what matters.
Heart rhythm care
Should I see an electrophysiologist about my heart rhythm and the possible need for an ICD?
Genetic counseling
Could a genetic counselor help me understand my specific variant?
Metabolic care
Should I see an endocrinologist or dietitian about metabolic changes?
Get notified when new evidence is published on LMNA-related cardiocutaneous progeria syndrome.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (15)
- 1
Cardiac diseases as a predictor warning of hereditary muscle diseases. The case of laminopathies.
D'Ambrosio P, Petillo R, Torella A, et al.
Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology 2019; (38(2)):33-36.
PMID: 31309180 - 2
Lamin A/C cardiomyopathy: young onset, high penetrance, and frequent need for heart transplantation.
Hasselberg NE, Haland TF, Saberniak J, et al.
European heart journal 2018; (39(10)):853-860 doi:10.1093/eurheartj/ehx596.
PMID: 29095976 - 3
Cardiac and Neuromuscular Features of Patients With LMNA-Related Cardiomyopathy.
Peretto G, Di Resta C, Perversi J, et al.
Annals of internal medicine 2019; (171(7)):458-463 doi:10.7326/M18-2768.
PMID: 31476771 - 4
Clinical Features of LMNA-Related Cardiomyopathy in 18 Patients and Characterization of Two Novel Variants.
Ferradini V, Cosma J, Romeo F, et al.
Journal of clinical medicine 2021; (10(21)) doi:10.3390/jcm10215075.
PMID: 34768595 - 5
A Novel Generalized Lipodystrophy-Associated Progeroid Syndrome Due to Recurrent Heterozygous LMNA p.T10I Mutation.
Hussain I, Patni N, Ueda M, et al.
The Journal of clinical endocrinology and metabolism 2018; (103(3)):1005-1014 doi:10.1210/jc.2017-02078.
PMID: 29267953 - 6
Diabetes mellitus coexisted with progeria: a case report of atypical Werner syndrome with novel LMNA mutations and literature review.
He G, Yan Z, Sun L, et al.
Endocrine journal 2019; (66(11)):961-969 doi:10.1507/endocrj.EJ19-0014.
PMID: 31270292 - 7
Nuclear Abnormalities in LMNA p.(Glu2Lys) Variant Segregating with LMNA-Associated Cardiocutaneous Progeria Syndrome.
Wilke MVMB, Wick M, Schwab TL, et al.
Genes 2024; (15(1)) doi:10.3390/genes15010112.
PMID: 38255001 - 8
Late gadolinium enhancement role in arrhythmic risk stratification of patients with LMNA cardiomyopathy: results from a long-term follow-up multicentre study.
Peretto G, Barison A, Forleo C, et al.
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2020; (22(12)):1864-1872 doi:10.1093/europace/euaa171.
PMID: 32995851 - 9
The Cardiovascular Magnetic Resonance Phenotype of Lamin Heart Disease.
Topriceanu CC, Al-Farih M, Joy G, et al.
JACC. Cardiovascular imaging 2025; (18(6)):644-660 doi:10.1016/j.jcmg.2025.01.004.
PMID: 40372342 - 10
Meta-analysis of the role of cardiac magnetic resonance in laminopathy.
Shahshenas S, Anissian A, Jalali Nadoushan M, Soltanipur M
Archives of cardiovascular diseases 2026; (119(5)):357-367 doi:10.1016/j.acvd.2026.02.003.
PMID: 41966904 - 11
Lipoatrophic diabetes in familial partial lipodystrophy type 2: From insulin resistance to diabetes.
Treiber G, Guilleux A, Huynh K, et al.
Diabetes & metabolism 2023; (49(2)):101409 doi:10.1016/j.diabet.2022.101409.
PMID: 36400409 - 12
Multisystem Progeroid Syndrome With Lipodystrophy, Cardiomyopathy, and Nephropathy Due to an LMNA p.R349W Variant.
Hussain I, Jin RR, Baum HBA, et al.
Journal of the Endocrine Society 2020; (4(10)):bvaa104 doi:10.1210/jendso/bvaa104.
PMID: 32939435 - 13
Familial partial lipodystrophy type 2 associated with a novel LMNA variant (c.604G>C; p.Glu202Gln): a Colombian family case series.
Mendoza C, Cano R, Burgos L, Silvera CA
Frontiers in endocrinology 2026; (17()):1788846 doi:10.3389/fendo.2026.1788846.
PMID: 42039119 - 14
Disease progression rate is a strong predictor of ventricular arrhythmias in patients with cardiac laminopathies: a primary prevention cohort study.
Rootwelt-Norberg C, Skjølsvik ET, Chivulescu M, et al.
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2023; (25(2)):634-642 doi:10.1093/europace/euac192.
PMID: 36352512 - 15
Location of LMNA Variants and Clinical Outcomes in Cardiomyopathy.
Bhaskaran A, Ben Yaou R, Helms AS, et al.
JAMA cardiology 2025; (10(9)):896-903 doi:10.1001/jamacardio.2025.2069.
PMID: 40601341
This page is for informational purposes only and does not constitute medical advice. An experienced inherited-cardiac and genetics team should tailor testing, monitoring, and treatment to your situation.